Ultragenyx Pharmaceutical Inc.RARE
Market cap
$3.2B
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -14.6 | -44.7 | -15.8 | -14.5 | -10.1 | -1.7 | -27.7 | -46.1 | -40 | -38 |
| Return on equity (%) |
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -14.6 | -44.7 | -15.8 | -14.5 | -10.1 | -1.7 | -27.7 | -46.1 | -40 | -38 |
| Return on equity (%) |